Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study
Background In 2021, about 500 million people were estimated to be living with type 2 diabetes throughout the world. The…
GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients
People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to…
Eli Lilly attacks weight-loss drug knockoffs as competition intensifies
Eli Lilly unleashed a flurry of lawsuits against wellness centers, medical spas and others the pharmaceutical company accused of illegally…
Zealand Deepens Weight-Loss Portfolio With Strong Phase Ib Data for GLP-1 Alternative
Zealand Pharma on Thursday posted interim Phase Ib data for its investigational amylin analog petrelintide, touting strong weight reduction and a favorable tolerability…
GLP-1 Receptor Agonists Improved Psoriasis Despite Diabetes Mellitus
In this systematic review and meta-analysis, the clinical efficacy of glucagon-like peptide 1 receptor agonists was evaluated. Credit: Pixabay Treating psoriasis with…
Zealand Pharma says weight loss drug could be comparable to GLP1-RAs
Zealand Pharma believes its weight loss drug petrelintide could be comparable to glucagon like peptide-1 receptor agonists (GLP1-RAs) while providing…
Endocrine Today: SURMOUNT-OSA Study Shows Tirzepatide improves sleep apnea symptoms for adults with OSA plus obesity
Key takeaways: ORLANDO — The GIP/GLP-1 dual agonist tirzepatide reduced symptoms of obstructive sleep apnea and improved multiple cardiometabolic markers…
Study: Semaglutide Lowered Chronic Kidney Disease–Related Risks
Chronic kidney disease, most commonly caused by diabetes and high blood pressure, puts more than half a billion people globally at high…
Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024
Novo Nordisk announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of…
Ozempic’s Hidden Challenges: A Personal Journey of Weight Loss and Self-Discovery
Author Johann Hari shares his experience with Ozempic, revealing both the benefits and unexpected psychological toll of the popular weight-loss…
